
Etrax40 mg
ACI Limited
Levamisole is an anthelmintic (antiparasitic) medicine used for the treatment of intestinal worm (helminth) infections.
Levamisole is an anthelmintic (antiparasitic) medicine used for the treatment of intestinal worm (helminth) infections.
Levamisole was formerly used at low doses as an immunomodulatory adjunct to chemotherapy (fluorouracil) in colon cancer, and it has also been used in veterinary medicine. These uses have been withdrawn/discontinued in human medicine in many countries, including removal of the cancer-adjunct product from the market, because of the risk of serious agranulocytosis. Levamisole is not recommended and should not be used for these purposes; its current, marketed human use is as an anthelmintic for intestinal worm infection.
Levamisole is usually given as a single oral dose, preferably after a light meal.
| Age Group | Dose |
|---|---|
| 1–4 years | 1 tablet (40 mg) or 5 mL oral suspension, as a single dose |
| 5–15 years | 2 tablets (80 mg) or 10 mL oral suspension, as a single dose |
| 16 years and above (adults) | 3 tablets (120 mg) or 15 mL oral suspension, as a single dose |
For heavy or severe hookworm infection, a repeat dose of the same strength may be given one to seven days after the first dose, on a physician's advice.
Complete the course of Levamisole exactly as prescribed. Do not repeat doses or use Levamisole more frequently than advised by a physician, and do not share this medicine with others, since inappropriate or repeated dosing has been linked to serious blood-cell side effects (see Precautions and Warnings).
Stool examination may be repeated after 2–3 weeks in persistent or heavy infections to confirm clearance, on the physician's advice.
Side effects of Levamisole are generally infrequent, mild, and transient when used at the recommended single anthelmintic dose.
Seek prompt medical attention for fever, sore throat, unusual bruising/bleeding, mouth ulcers, or signs of infection during or after taking Levamisole, or for any severe or persistent symptoms.
Levamisole is contraindicated in:
Levamisole should not be used during pregnancy (see Pregnancy and Lactation for detailed guidance) and is not recommended for the historical low-dose immunomodulatory/chemotherapy-adjunct use because of the risk of serious agranulocytosis (see Precautions and Warnings).
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.